课题基金 / 基金详情

Study on ECM tenascin-family proteins by gene knockout

Study on ECM tenascin-family proteins by gene knockout
ECM腱蛋白家族蛋白基因敲除研究
批准号:
07044209
负责人:
IKEMURA Toshimichi
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 --

项目摘要

项目成果

IKEMURA Toshimichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The tenascins are a growing family of extracellular matrix glycoproteins.To date three members of the family have been identified in mammals : tenascin-C (TN-C) (also called cytotactin), tenascin-R (TN-R) (for restrictin), and tenascin-X (TN-X).We have identified that TN-X gene is localized in the class III region of the major histocompatibility complex locus and the expression of TN-X is often reciprocal to that of TN-C in the developing mouse embryo.In order to test the possible involvement of TN-X in embryonic migrations and morphogenetic processes and in later events such as wound healing and oncogenesis, we have used homologous recombination in embryonic stem (ES) cells to inactivate the TN-X gene.Now we are attempting to generate strains of mice deficient in TN-X.Thus far we have constructed the targeting vectors which disrupt TN-X gene by deletion of the 5' portion removing the translation initiation codon.By using of the targeting vector, we have identified the two targeted clones among 1200 G418-resistant transfectants analyzed.To generate mice harboring the targeted TN-X allele, these targeted ES cell clones were injected into host 8-cell stage embryo.However no extensive ES-cell contribution was observed with the two clones as assayd by coat color chimerism, indicating that all chimeric embryos with high ES-cell contribution die between E13 and E16.The reason why these chimeric embryos die earlier in gestation remains to be determined.Further experiments should help to clarify this issue.As for the regulation of TN-X expression, Dr.Chiquet-Ehrismann (Friedrich Miescher Institute, Switzerland) has investigated the expression of TN-X in fibroblasts and carcinoma cells in culture.None of the growth factors or cytokines examined affected the expression level of TN-X,however, steroid hormone glucocorticoids, were found to downregulate TN-X mRNA levels and protein synthesis in fibroblasts but not carcinoma cells at physiological concentrations.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
T.Sakai, Y.Furukawa, R.Chiquet-Ehrismann, M.Nakamura, S.Kitagawa, T.Ikemura, and K.Matsumoto: "Tenascin-X Expression in Tumor Cells and Fibroblasts : Glucocorticoids as Potent Inhibitors in Fibroblasts" Journal of Cell Science. in press. (1996)
T.Sakai、Y.Furukawa、R.Chiquet-Ehrismann、M.Nakamura、S.Kitakawa、T.Ikemura 和 K.Matsumoto:“肿瘤细胞和成纤维细胞中的 Tenascin-X 表达:糖皮质激素作为成纤维细胞中的有效抑制剂”期刊
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Sakai,Y.Furukawa,R.Chiquet-Ehrismann,M.Nakamura,S.Kitagawa,T.Ikemura,and K.Matumoto: "Tenascin-X Expression in Tumor Cells and Fibroblasts:Glucocorticoids as Potent Inhibitors in Fibroblasts" Journal of Cell Science. (印刷中). (1996)
T. Sakai、Y. Furukawa、R. Chiquet-Ehrismann、M. Nakamura、S. Kitakawa、T. Ikemura 和 K. Matumoto:“肿瘤细胞和成纤维细胞中的 Tenascin-X 表达:糖皮质激素作为成纤维细胞中的有效抑制剂”期刊细胞科学(正在出版)(1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Genomic sequence studies of zoonotic disease viruses including influenza viruses with a novel bioinformatics method
Function prediction of poorly-characterized protein genes found in genome sequences with high-performance supercomputers and its publication
Sequence alignment-free method for phylogenetic and functional prediction and its application to molecular evolutionary studies
Bioinformatics strategy for unveiling hidden genome signatures and biodiversity
国内基金
海外基金
Tenascin-C促进巨噬细胞向肌成纤维细胞转化在肾脏纤维化中的作用机制研究
  • 批准号:
    82300792
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    田媛
  • 依托单位:
基于类器官探究Tenascin-C小分子多肽对肾纤维化的防治作用及其机制
  • 批准号:
    82300761
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    梁剑青
  • 依托单位:
柔肝方下调Tenascin-C改善HIF-1α/PFKFB3介导的巨噬细胞糖酵解抗肝纤维化的机制研究
  • 批准号:
    82374249
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    李曼
  • 依托单位:
肺泡上皮细胞过度内质网应激释放外泌体Tenascin-C放大炎症效应加重脓毒症急性肺损伤
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    刘友坦
  • 依托单位: